Hematology NewsNovel mutations contribute to progression of venetoclax-treated CLLFebruary 2, 2020CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsOfatumumab works safely for elderly patients with CLL, comorbiditiesJanuary 22, 2020CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020Cellular TherapyTransplantCLLTransplantationMixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology News9/11 responders show increased risk of leukemia, other cancersJanuary 14, 2020Leukemia, Myelodysplasia, TransplantationAMLCLL
Hematology NewsCAR T-cell therapy advances in CLLDecember 26, 2019CLLCellular TherapyB Cell LymphomaLeukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
Hematology NewsLOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignanciesDecember 20, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell DisordersCLL
Hematology NewsZanubrutinib achieved high response rate in del(17p) CLL cohortDecember 16, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsEfficacy of postvenetoclax therapy may depend on prior agent exposure in CLLDecember 10, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology NewsOff-the-shelf cellular therapy shows promise in the labDecember 8, 2019B Cell LymphomaCLLCellular TherapyImmuno-oncologyImmunotherapy
Hematology NewsFDA approves acalabrutinib for CLL, SLL treatmentNovember 21, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsFrontline ibrutinib saves money over chemoimmunotherapyNovember 20, 2019CLLBusiness of MedicinePractice ManagementB Cell Lymphoma
Hematology NewsGene signature may help guide initial CLL treatment choiceNovember 14, 2019CLLB Cell LymphomaLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsConsider renal function in TLS risk assessment of venetoclax-treated CLLOctober 29, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsPJP prophylaxis may be unnecessary for CLL patients on BTK inhibitorsOctober 16, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsTargeted agents vs. chemoimmunotherapy as first-line treatment of CLLOctober 3, 2019CLLLymphoma & Plasma Cell DisordersB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
